Genetic determinants of alcoholic liver disease

Gut

Volumn 61, Issue 1, 2012, Pages 150-159

  Stickel, Felix ^a   Hampe, Jochen ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALCOHOLISM; ANTIOXIDANT ACTIVITY; CANCER RISK; CASE CONTROL STUDY; CHOLELITHIASIS; CHRONIC LIVER DISEASE; COMORBIDITY; DIET; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; FATTY LIVER; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HEREDITY; HOST; HUMAN; INFLAMMATION; LIPID STORAGE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PATIENT COMPLIANCE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; TWIN ZYGOSITY;

ALCOHOLISM; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPASE; LIVER DISEASES, ALCOHOLIC; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 83455259910     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301239     Document Type: Review

References (85)

1. Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997;41:845-50.
2. Becker U, Deis A, Sorensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23:1025-9. (Pubitemid 26137041)
3. Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127 (5 Suppl 1):S35-50. (Pubitemid 39423368)
4. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-612. (Pubitemid 47106631)
5. Wang Y, Millonig G, Nair J, et al. Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 2009;50:453-61.
6. Wu D, Cederbaum AI. Oxidative stress and alcoholic liver disease. Semin Liver Dis 2009;29:141-54.
7. Lu Y, Zhug J, Wang X, et al. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 2008;47:1483-94. (Pubitemid 351702732)
8. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19. (Pubitemid 40163989)
9. Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol. Published Online First: 2011. doi:10.1038/nrgastro.2011.134.
10. Stickel F, Herold C, Seitz HK, et al. Alcohol and methyl transfer: implication for alcohol related hepatocarcinogenesis. In: Ali S, Friedman SL, Mann DA, eds. Liver Disease: Biochemical Mechanisms and New Therapeutic Insights. Plymouth, Jersey, Enfield: Science Publishers (USA), 2006:45-58.
11. Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003;124:1488-99. (Pubitemid 36531821)
12. Garcia-Trevijano ER, Iraburu MJ, Fontana L, et al. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta dependent mechanism in rat hepatic stellate cells. Hepatology 1999;29:960-70. (Pubitemid 29109616)
13. Svegliati-Baroni G, Inagaki Y, Rincon-Sanchez AR, et al. Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. Hepatology 2005;42:343-52. (Pubitemid 41061087)
14. Arthur MJ, Iredale JP, Mann DA. Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 1999;23:940-3. (Pubitemid 29256587)
15. Naveau S, Cassard-Doulcier AM, Njiké-Nakseu M, et al. Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. J Hepatol 2010;52:895-902.
16. Monto A, Patel K, Bostrom A, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004;39:826-34. (Pubitemid 38337664)
17. Parés A, Caballería J, Bruguera M, et al. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986;2:33-42. (Pubitemid 16177384)
18. Sato N, Lindros KO, Baraona E, et al. Sex difference in alcoholrelated organ injury. Alcohol Clin Exp Res 2001;25:40Se5S.
19. Eagon PK. Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol 2010;16:1377-84.
20. Frezza M, di Padova C, Pozzato G, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990;322: 95-9. (Pubitemid 20023867)
21. Wickramasinghe SN, Corridan B, Izaguirre J, et al. Ethnic differences in the biological consequences of alcohol abuse: a comparison between south Asian and European males. Alcohol Alcohol 1995;30:675-80.
22. Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res 2001;25:1181-7. (Pubitemid 32758470)
23. Whitfield JB, Zhu G, Heath AC, et al. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res 2001;25:1037-45. (Pubitemid 32656121)
24. Grove J, Daly AK, Burt AD, et al. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 1998;43:262-6. (Pubitemid 28348332)
25. Gleeson D, Evans S, Bradley M, et al. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls. Am J Gastroenterol 2006;101:304-10. (Pubitemid 43381672)
26. Stickel F, Österreicher CH. Genetic factors in alcoholic liver disease. Alcohol Alcohol 2006;41:209-24.
27. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003;37:493-503. (Pubitemid 36258768)
28. Lazaridis KN, Juran BD. American Gastroenterological Association future trends committee report: the application of genomic and proteomic technologies to digestive disease diagnosis and treatment and their likely impact on gastroenterology clinical practice. Gastroenterology 2005;129:1720-52. (Pubitemid 41597410)
29. Anstee QM, Daly AK, Day CP. Genetics of alcoholic and nonalcoholic liver disease. Semin Liv Dis 2011;31:128-46.
30. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nat Rev Genet 2005;6: 521-32. (Pubitemid 40910429)
31. Warner L A, White HR, Johnson V. Alcohol initiation experiences and family history of alcoholism as predictors of problem-drinking trajectories. J Stud Alcohol Drugs 2007;68:56-65.
32. Williams JT, Begleiter H, Porjesz B, et al. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. II. Alcoholism and event-related potentials. Am J Hum Genet 1999;65:1148-60. (Pubitemid 30462972)
33. Long JC, Knowler WC, Hanson RL, et al. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet 1998;81:216-21. (Pubitemid 28211181)
34. Reich T, Edenberg HJ, Goate A, et al. Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet 1998;81:207-15. (Pubitemid 28211180)
35. Edenberg HJ, Dick DM, Xuei X, et al. Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 2004;74:705-14. (Pubitemid 38420099)
36. Fehr C, Sander T, Tadic A, et al. Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis. Psychiatr Genet 2006;16:9-17. (Pubitemid 44481214)
37. Crabb DW, Matsumoto M, Chang D, et al. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004;63:49-63. (Pubitemid 38543873)
38. Zintzaras E, Stefanidis I, Santos M, et al. Do alcohol-metabolizing gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 2006;43:352-61.
39. Homann N, Stickel F, König IR, et al. The alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int J Cancer 2006;118:1998-2002.
40. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003;124:778-90. (Pubitemid 36268494)
41. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154-66.
42. Berhane K, Widersten M, Fangström A, et al. Detoxication of propenals and other a,b-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci USA 1994;91:1480-4. (Pubitemid 24059036)
43. Stickel F, Österreicher CH, Ferenci P, et al. A functional polymorphism in the glutathione-S-transferase P1 gene determined the progression to cirrhosis in hereditary hemochromatosis but not in chronic hepatitis C. Arch Intern Med 2005;165:1835-40.
44. Khan AJ, Husain Q, Choudhuri G, et al. Association of polymorphism in alcohol dehydrogenase and interaction with other genetic risk factors with alcoholic liver cirrhosis. Drug Alcohol Depend 2010;109:190-7.
45. Wallace DC. Mitochondrial disease in man and mouse. Science 1999;283:1482-8.
46. Sutton A, Khoury H, Prip-Buus C, et al. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-57. (Pubitemid 36324244)
47. Degoul F, Sutton A, Mansouri A, et al. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 2001;120:1468-74. (Pubitemid 32322321)
48. Stewart SF, Leathart JB, Chen Y, et al. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 2002;36:1355-60. (Pubitemid 35403525)
49. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med 2004;10:355-61. (Pubitemid 38508511)
50. Rey JW, Noetel A, Hardt A, et al. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol 2010;16:5830-7.
51. Hernández-Nazará ZH, Ruiz-Madrigal B, Martínez- López E, et al. Association of the epsilon 2 allele of APOE gene to hypertriglyceridemia and to early-onset alcoholic cirrhosis. Alcohol Clin Exp Res 2008;32:559-66. (Pubitemid 351430419)
52. Frenzer A, Butler WJ, Norton ID, et al. Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol 2002;17:177-82. (Pubitemid 34415671)
53. Jun DW, Han JH, Jang EC, et al. Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine N-methyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans. Eur J Gastroenterol Hepatol 2009;21:667-72.
54. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009;360:2758-69.
55. Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 2009;50:1258-66.
56. Järveläinen HA, Orpana A, Perola M, et al. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001;33:1148-53. (Pubitemid 32378214)
57. Campos J, Gonzalez-Quintela A, Quinteiro C, et al. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol Clin Exp Res 2005;29:1206-13. (Pubitemid 41060436)
58. Meiler C, Muhlbauer M, Johann M, et al. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J Gastroenterol 2005;11:6031-7. (Pubitemid 41749222)
59. Martins A, Cortez-Pinto H, Machado M, et al. Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease? Eur J Gastroenterol Hepatol 2005;17:1099-104. (Pubitemid 41424004)
60. Grove J, Daly AK, Bassendine MF, et al. Interleukin 10 promoter region polymorphism and susceptibility to advanced alcoholic liver disease. Gut 2000;46:540-5. (Pubitemid 30305820)
61. Ladero JM, Fernandez-Arquero M, Tudela JI, et al. Single nucleotide polymorphisms and microsattelite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced alcoholic liver disease. Liver 2002;22:245-51. (Pubitemid 34846363)
62. Bathgate AJ, Pravica V, Perrey C, et al. Polymorphisms in tumor necrosis factor alpha, interleukin-10 and transforming growth factor b 1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 2000;12:1329-33. (Pubitemid 32057375)
63. Marcos M, Gómez-Munuera M, Pastor I, et al. Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol 2009;170:948-56.
64. Takamatsu M, Yamauchi M, Maezawa Y, et al. Correlation of a polymorphism in the interleukin-1 receptor antagonist gene with hepatic fibrosis in Japanese alcoholics. Alcohol Clin Exp Res 1998;22:141Se4S.
65. Pastor I, Laso FJ, Avila JJ, et al. Polymorphism in the interleukin-1 receptor antagonist gene is associated with alcoholism in Spanish men. Alcohol Clin Exp Res 2000;24:1479-82.
66. Takamatsu M, Yamauchi M, Maezawa Y, et al. Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 2000;95:1305-11. (Pubitemid 30263529)
67. Valenti L, De Feo T, Fracanzani AL, et al. Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients. Alcohol Alcohol 2004;39:276-80. (Pubitemid 38968080)
68. Stickel F, Österreicher CH, Halangk J, et al. No role of matrixmetalloproteinase-3 genetic promoter polymorphism as a risk factor for cirrhosis in alcoholic liver disease. Alcohol Clin Exp Res 2008;32:959-65. (Pubitemid 351733077)
69. Österreicher CH, Halangk J, Berg T, et al. Evaluation of the transforming growth factor beta-1 codon 25 (Arg→Pro) polymorphism in alcoholic liver disease. Cytokine 2008;42:18-23.
70. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011;53:1883-94.
71. Tian C, Stokowski RP, Kershenobich D, et al. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 2010;42:21-3.
72. Seth D, Daly AK, Haber PS, et al. Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology 2010;51:1463-5.
73. Trépo E, Gustot T, Degré D, et al. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol 2011;55:906-12.
74. Stickel F, Buch S, Lau K, et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 2011;53:86-95.
75. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004;306:1383-6. (Pubitemid 39532517)
76. Huang Y, He S, Li JZ, et al. A feed-forward loop amplifies nutritional regulations of PNPLA3. Proc Natl Acad Sci USA 2010;107:7892-7.
77. Lake AC, Sun Y, Li JL, et al. Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. J Lipid Res 2005;46:2477-87. (Pubitemid 41532536)
78. Hoekstra M, Li Z, Kruijt JK, et al. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol 2010;52:244-51.
79. Baulande S, Lasnier F, Lucas M, et al. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 2001;276:33336-44.
80. He S, McPhaul C, Li JZ, et al. A sequence variation (I148M) in PNPlA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2009;285:6706-15.
81. Basantani MK, Sitnick MT, Cai L, et al. Pnpla3/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 2011;52:318-29.
82. Chen W, Chang B, Li L, et al. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 2010;52:1134-42.
83. Trépo E, Pradat P, Potthoff A, et al. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology 2011;54:60-9.
84. Müller T, Buch S, Berg T, et al. Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C. J Hepatol 2011;55:1471-2.
85. Zimmer V, Lammert F. Genetics in liver disease: new concepts. Curr Opin Gastroenterol 2011;27:231-9.